These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22333622)

  • 1. Nitric oxide: considerations for the treatment of ischemic stroke.
    Terpolilli NA; Moskowitz MA; Plesnila N
    J Cereb Blood Flow Metab; 2012 Jul; 32(7):1332-46. PubMed ID: 22333622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO: the primary EDRF.
    Fleming I; Busse R
    J Mol Cell Cardiol; 1999 Jan; 31(1):5-14. PubMed ID: 10072711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelium-formed nitric oxide on vascular responses.
    Marín J; Sánchez-Ferrer CF
    Gen Pharmacol; 1990; 21(5):575-87. PubMed ID: 2276579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact and altered endothelium in regulation of vasomotion.
    Lerman A; Burnett JC
    Circulation; 1992 Dec; 86(6 Suppl):III12-19. PubMed ID: 1424046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing and contracting factors.
    Rubanyi GM
    J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
    Bauer V; Sotníková R
    Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus.
    Raij L; Shultz PJ
    J Am Soc Nephrol; 1993 Feb; 3(8):1435-41. PubMed ID: 8387828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and the cerebral circulation.
    Faraci FM; Brian JE
    Stroke; 1994 Mar; 25(3):692-703. PubMed ID: 7510430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the relationship between the endothelium derived relaxant factor and nitric oxide?
    Long CJ; Berkowitz BA
    Life Sci; 1989; 45(1):1-14. PubMed ID: 2664391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelium-derived relaxing factor (EDRF)].
    Toda N; Okamura T
    Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):295-308. PubMed ID: 2165993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of NO and EDRF from cultured bovine aortic endothelial cells.
    Myers PR; Guerra R; Harrison DG
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1030-7. PubMed ID: 2784944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E
    Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Parker JL; Tanner MA; Adams HR
    Shock; 1994 Jan; 1(1):73-8. PubMed ID: 7743332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitric oxide-dependent endogenous and exogenous vasodilators. The mechanism of action of nitrates].
    Machado AP; Alcântara P
    Rev Port Cardiol; 1995 Jan; 14(1):61-71. PubMed ID: 7695956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenic tone as a therapeutic target for ischemic stroke.
    Palomares SM; Cipolla MJ
    Curr Vasc Pharmacol; 2014; 12(6):788-800. PubMed ID: 24066932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications.
    Feng Q; Hedner T
    Clin Physiol; 1990 Sep; 10(5):407-26. PubMed ID: 2245592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.